Skip to content
Trial Eligibility
Menu

Exploring Sympathetic Nervous System Function in Individuals With Down Syndrome

NCT07238465

This study is recruiting at 1 US site in 1 state, according to its ClinicalTrials.gov record last updated .

Summary

Down syndrome (DS), the most common genetic cause of intellectual disability, is associated with widespread organ dysfunction, including abnormalities in the autonomic nervous system (ANS). The ANS regulates critical functions such as heart rate (HR) and blood pressure (BP), both essential for maintaining homeostasis and supporting physical activity. Individuals with DS often exhibit blunted HR responses to exercise-typically ~30 beats per minute below expected levels-suggesting reduced sympathetic nervous system (SNS) activity.

Shortened from the sponsor's brief summary. View official record on ClinicalTrials.gov

Conditions studied

  • Down Syndrome
  • Autonomic Dysfunction

Eligibility basics and study details

Study type
Interventional
Phase
Phase 3
Ages
18 to 50 years
Sex
All
Healthy volunteers
Accepted
Sponsor
University of Colorado, Denver
Last updated on ClinicalTrials.gov
October 13, 2026

These are the basic criteria only. The full inclusion and exclusion criteria are on the official record, and the study team decides who can take part.

US recruiting sites

Colorado · 1

  • Linda Crnic Institute for Down Syndrome, University of Colorado Anschutz Medical Campus · Aurora, CO

Source: ClinicalTrials.gov, data processed . Recruiting US sites filtered by distance and site status; summaries shortened.